M James Lozada1, Stephanie Cai, Marissa Li, Stephanie Lynne Davidson, Justin Nix, Glenn Ramsey. 1. From the Department of Anesthesiology (M.J.L.), Vanderbilt University Medical Center, Nashville, Tennessee; Northwestern University Feinberg School of Medicine (S.C.), Chicago, Illinois; United Blood Services (M.L.), Las Vegas, Nevada; Department of Anesthesiology (S.L.D.), Sunrise Hospital and Medical Center, Sunrise Children's Hospital, Las Vegas, Nevada; School of Criminology and Criminal Justice (J.N.), University of Nebraska Omaha, Omaha, Nebraska; and Department of Pathology (G.R.), Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Abstract
BACKGROUND: The deadliest mass shooting in modern United States history occurred on October 1, 2017, in Las Vegas, killing 58 and overwhelming hospitals with more than 600 injured. The scope of the tragedy offers insight into medical demands, which may help guide preparedness for future mass shooting incidents. METHODS: Retrospective, deidentified, health care institution-provided data from all hospitals and blood banks providing care to Las Vegas shooting victims were gathered. Study authors independently reviewed all data and cross-referenced it for verification. Main outcomes and measures include the number of victims requiring hospital and intensive care admission, the amount and types of blood components transfused during the first 24 hours, and the amount of blood donated to local blood banks following the Las Vegas mass shooting. RESULTS: Two hundred twenty patients required hospital admission, 68 of them to critical care. Nearly 500 blood components were transfused during the first 24 hours in a red blood cell-to-plasma-to-platelet ratio of 1:0.54:0.81. Public citizens donated almost 800 units of blood immediately after the shooting; greater than 17% of this donated blood went unused. CONCLUSIONS: The amount of blood components transfused per patient admitted was similar in magnitude to other mass casualty events, and available blood supply met patient demand. The public call for blood donors was not necessary to meet immediate demand and led to resource waste. Preparation for future mass shooting incidents should include training the community in hemorrhage control, encouraging routine blood donation, and avoiding public calls for blood donation unless approved by local blood suppliers. LEVEL OF EVIDENCE: Therapeutic study, level V.
BACKGROUND: The deadliest mass shooting in modern United States history occurred on October 1, 2017, in Las Vegas, killing 58 and overwhelming hospitals with more than 600 injured. The scope of the tragedy offers insight into medical demands, which may help guide preparedness for future mass shooting incidents. METHODS: Retrospective, deidentified, health care institution-provided data from all hospitals and blood banks providing care to Las Vegas shooting victims were gathered. Study authors independently reviewed all data and cross-referenced it for verification. Main outcomes and measures include the number of victims requiring hospital and intensive care admission, the amount and types of blood components transfused during the first 24 hours, and the amount of blood donated to local blood banks following the Las Vegas mass shooting. RESULTS: Two hundred twenty patients required hospital admission, 68 of them to critical care. Nearly 500 blood components were transfused during the first 24 hours in a red blood cell-to-plasma-to-platelet ratio of 1:0.54:0.81. Public citizens donated almost 800 units of blood immediately after the shooting; greater than 17% of this donated blood went unused. CONCLUSIONS: The amount of blood components transfused per patient admitted was similar in magnitude to other mass casualty events, and available blood supply met patient demand. The public call for blood donors was not necessary to meet immediate demand and led to resource waste. Preparation for future mass shooting incidents should include training the community in hemorrhage control, encouraging routine blood donation, and avoiding public calls for blood donation unless approved by local blood suppliers. LEVEL OF EVIDENCE: Therapeutic study, level V.
Authors: Stephen Y Liang; LinLin Tian; Garrett A Cavaliere; Benjamin J Lawner; Gregory N Jasani Journal: Prehosp Disaster Med Date: 2022-08-09 Impact factor: 2.866
Authors: Patrick Melmer; Margo Carlin; Christine A Castater; Deepika Koganti; Stuart D Hurst; Brett M Tracy; April A Grant; Keneeshia Williams; Randi N Smith; Christopher J Dente; Jason D Sciarretta Journal: J Multidiscip Healthc Date: 2019-12-10
Authors: Jefferson M Jones; Mathew R P Sapiano; Alexandra A Savinkina; Kathryn A Haass; Misha L Baker; Richard A Henry; James J Berger; Sridhar V Basavaraju Journal: Transfusion Date: 2020-02-21 Impact factor: 3.337
Authors: Richard B Weiskopf; Elon Glassberg; Nicole R Guinn; Michael F M James; Paul M Ness; Anthony E Pusateri Journal: Transfusion Date: 2020-11-20 Impact factor: 3.337
Authors: Richard R Gammon; Lizabeth Rosenbaum; Rhonda Cooke; Mark Friedman; Linda Rockwood; Tracie Nichols; Sarah Vossoughi Journal: Transfusion Date: 2020-11-18 Impact factor: 3.337